The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
mFOLFOXIRI with or without cetuximab as conversion therapy in patients with RAS/BRAF wild-type unresectable liver metastases colorectal cancer: The FOCULM study.
 
Huabin Hu
No Relationships to Disclose
 
Kun Wang
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Meng Qiu
No Relationships to Disclose
 
Rongbo Lin
No Relationships to Disclose
 
Haibo Zhang
No Relationships to Disclose
 
GuangJian Liu
No Relationships to Disclose
 
Yunle Wan
No Relationships to Disclose
 
Liang Kang
No Relationships to Disclose
 
Hui Wang
No Relationships to Disclose
 
Zhiyang Zhou
No Relationships to Disclose
 
Fangqian Li
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Jianwei Zhang
No Relationships to Disclose
 
Yue Cai
No Relationships to Disclose
 
Zehua Wu
No Relationships to Disclose
 
Jiayu Ling
No Relationships to Disclose
 
Meijin Huang
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose